| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |